You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rituximab

Showing 2351 - 2375 of 2,665
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +42 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013

B-cell Adult Acute Lymphoblastic Leukemia, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Columbus (rituximab, aldesleukin,

Completed
  • B-cell Adult Acute Lymphoblastic Leukemia
  • +52 more
  • rituximab
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 5, 2013

Bendamustine With or Without Rituximab in Chronic

Completed
  • Chronic Lymphocytic Leukaemia
    • Cosenza, CZ, Italy
    • +2 more
    Apr 12, 2013

    Lymphoma Trial in Houston (Zevalin, Rituximab, ^111 In Ibritumomab Tiuxetan)

    Terminated
    Has Results
    • Lymphoma
    • Houston, Texas
      UT MD Anderson Cancer Center
    May 30, 2013

    Lymphoma Trial in United States (autologous immunoglobulin idiotype-KLH conjugate vaccine, rituximab, sargramostim)

    Terminated
    • Lymphoma
    • autologous immunoglobulin idiotype-KLH conjugate vaccine
    • +2 more
    • Birmingham, Alabama
    • +59 more
    Aug 1, 2013

    Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Giessen (Bendamustine plus Rituximab, Fludarabine 25 mg/m² d 1-3 +

    Completed
    • Non-Hodgkin's Lymphoma
    • Mantle Cell Lymphoma
    • Bendamustine plus Rituximab
    • Fludarabine 25 mg/m² d 1-3 + Rituximab 375 mg/m² d 1 q4w
    • Giessen, Germany
      StiL Head Office; Justus-Liebig-University
    Feb 11, 2013

    C-peptide in Youth With Longstanding Type 1 Diabetes Mellitus

    Completed
    • Type 1 Diabetes Mellitus
    • Boost shake
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    May 2, 2014

    Lymphoma Trial in Worldwide (biological, drug, procedure)

    Completed
    • Lymphoma
    • filgrastim
    • +8 more
    • Sydney, New South Wales, Australia
    • +130 more
    Sep 16, 2013

    Lymphoma Trial in Belgium, Netherlands (biological, drug, procedure, radiation)

    Completed
    • Lymphoma
    • filgrastim
    • +12 more
    • Leuven, Belgium
    • +16 more
    Aug 9, 2013

    Leukemia Trial in Worldwide (Rituximab, Cyclophosphamide, Fludarabine Phosphate)

    Completed
    Has Results
    • Leukemia
    • Rituximab
    • +2 more
    • Gosford, New South Wales, Australia
    • +161 more
    Sep 9, 2013

    Rheumatoid Arthritis Trial in Denver (Rituximab)

    Terminated
    Has Results
    • Rheumatoid Arthritis
    • Rituximab
    • Denver, Colorado
      University of Colorado Health Sciences Center
    Feb 6, 2013

    Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Cyclophosphamide, Fludarabine, Alemtuzumab)

    Completed
    Has Results
    • Leukemia
    • Chronic Lymphocytic Leukemia
    • Houston, Texas
      The University of Texas M.D. Anderson Cancer Center
    Jan 25, 2013

    Glomerulonephritis, Membranoproliferative Trial in Rochester (Rituximab)

    Completed
    • Glomerulonephritis, Membranoproliferative
    • Rituximab
    • Rochester, Minnesota
      Mayo Clinic
    Jan 15, 2013

    Nephrotic Syndrome Trial in Italy (Rituximab)

    Completed
    • Nephrotic Syndrome
    • Rituximab
    • Bergamo, Italy
    • +6 more
    Feb 22, 2013

    GVHD Trial in Italy (polyclonal antibody, Rituximab, Treosulfan)

    Unknown status
    • Graft Versus Host Disease
    • polyclonal antibody
    • +6 more
    • Cagliari, Italy
    • +3 more
    Mar 12, 2013

    Relapsed Follicular Lymphoma Trial in Puerto Rico, United States (rituximab, cyclophosphamide, doxorubicin)

    Completed
    Has Results
    • Relapsed Follicular Lymphoma
    • rituximab
    • +4 more
    • Muscle Shoals, Alabama
    • +42 more
    Apr 26, 2013

    Leukemia, Lymphoma Trial in United States (rituximab, pentostatin)

    Completed
    • Leukemia
    • Lymphoma
    • Rancho Mirage, California
    • +4 more
    Feb 1, 2013

    Lymphoma, Diffuse Large Cell Trial in St. Louis (Blood draw)

    Completed
    • Lymphoma
    • Diffuse Large Cell
    • Blood draw
    • St. Louis, Missouri
      Washington University School of Medicine
    May 14, 2013

    Refractory Myasthenia Gravis Trial in Syracuse, Burlington (Rituximab (Rituxan))

    Completed
    • Refractory Myasthenia Gravis
    • Rituximab (Rituxan)
    • Syracuse, New York
    • +1 more
    Jan 15, 2013

    Anaplastic Large Cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Chicago,

    Completed
    Has Results
    • Anaplastic Large Cell Lymphoma
    • +5 more
    • Chicago, Illinois
    • +1 more
    May 7, 2014

    Renal Insufficiency Trial in Taipei (rituximab and everolimus, thymoglobulin and tacrolimus)

    Terminated
    • Renal Insufficiency
    • rituximab and everolimus
    • thymoglobulin and tacrolimus
    • Taipei, Taiwan
      National Taiwan University Hospital
    Dec 26, 2012

    Lymphoma Trial in New York (rituximab, yttrium Y 90 ibritumomab tiuxetan)

    Completed
    • Lymphoma
    • rituximab
    • yttrium Y 90 ibritumomab tiuxetan
    • New York, New York
      Memorial Sloan - Kettering Cancer Center
    Jan 15, 2013

    Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage III Adult

    Terminated
    • Contiguous Stage II Adult Diffuse Large Cell Lymphoma
    • +3 more
    • oblimersen sodium
    • +6 more
    • San Antonio, Texas
      Southwest Oncology Group
    Jan 4, 2013

    Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma Trial in

    Terminated
    • Stage III Grade 1 Follicular Lymphoma
    • +5 more
    • oblimersen sodium
    • +2 more
    • Chicago, Illinois
      Cancer and Leukemia Group B
    Jan 4, 2013

    Lymphoma Trial in Shanghai (nucleoside analog reverse transcriptase inhibitor)

    Unknown status
    • Lymphoma
    • nucleoside analog reverse transcriptase inhibitor
    • Shanghai, Shanghai, China
    • +1 more
    Jan 7, 2014